Literature DB >> 9703520

Cholesterol: how low is low enough?

A Rosengren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9703520      PMCID： PMC1113708          DOI： 10.1136/bmj.317.7156.425

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

Review 1.  Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology.

Authors: 
Journal:  Eur Heart J       Date:  1997-03       Impact factor: 29.983

2.  Treatment goals for low-density lipoprotein cholesterol in the secondary prevention of coronary heart disease: absolute levels or extent of lowering?

Authors:  P Cullen; G Assmann
Journal:  Am J Cardiol       Date:  1997-11-15       Impact factor: 2.778

3.  Percentage change rather than plasma level of LDL-cholesterol determines therapeutic response in coronary heart disease.

Authors:  G R Thompson; J Hollyer; D D Waters
Journal:  Curr Opin Lipidol       Date:  1995-12       Impact factor: 4.776

4.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

5.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

6.  Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations.

Authors:  Z Chen; R Peto; R Collins; S MacMahon; J Lu; W Li
Journal:  BMJ       Date:  1991-08-03

7.  Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland.

Authors:  E Vartiainen; P Puska; J Pekkanen; J Tuomilehto; P Jousilahti
Journal:  BMJ       Date:  1994-07-02

8.  Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study.

Authors:  M R Law; N J Wald; T Wu; A Hackshaw; A Bailey
Journal:  BMJ       Date:  1994-02-05

9.  W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators.

Authors: 
Journal:  Lancet       Date:  1980-08-23       Impact factor: 79.321

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245
  10 in total
  2 in total

1.  Cholesterol: how low is low enough? Effect of a given concentration depends on several factors.

Authors:  A R Walker
Journal:  BMJ       Date:  1999-02-20

2.  National service framework for coronary heart disease. Ambiguities need to be clarified.

Authors:  R Lloyd-Mostyn
Journal:  BMJ       Date:  2000-09-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.